美股ETF漲幅Top20 | 港股賺完還不夠?12只中國科技ETF被挖出來了,CWEB一夜大漲19%
最近港股的勢頭完全蓋過了美股,11月以來恆指漲了25%,標普卻只漲了3%,投資者在港股賺完還嫌不夠,挖掘出了美股市場上相關的港股標的。
11月15日,恆生科技指數大漲7.3%,美股ETF漲幅前20中有12只是港股和科技股相關的,其中兩倍做多中國海外互聯網股票ETF(代碼CWEB)漲19.1%,位列榜1,大家比較熟悉的可能是KWEB,成分股包括港股的ATMJ等,CWEB追蹤同一指數,只是加了2倍槓桿。
三倍、兩倍做多富時中國50指數ETF(代碼YINN、XPP)分別漲15.4%、10.1%,擠進漲幅榜前3。前段時間大家可能交易三倍做空富時中國50指數ETF(YANG)賺翻了,現在是時候看看做多的了。
美股市場也有追蹤恆生科技指數的ETF,代碼是KTEC,週二也漲了8%,追蹤金龍中國指數的PGJ漲7.3%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.